1.
Ashoush N. REVIEW ONPHARMACOKINETICS OF EMPAGLIFLOZIN, AN INHIBITOR OF THE SODIUM GLUCOSE CO-TRANSPORTER-2 (SGLT-2). Asian J Pharm Clin Res [Internet]. 2017 Jul. 1 [cited 2024 Nov. 22];10(7):50-6. Available from: https://journals.innovareacademics.in/index.php/ajpcr/article/view/18067